268 related articles for article (PubMed ID: 8256796)
1. The role of bisphosphonates in the prevention and treatment of osteoporosis.
Papapoulos SE
Am J Med; 1993 Nov; 95(5A):48S-52S. PubMed ID: 8256796
[TBL] [Abstract][Full Text] [Related]
2. Current bone mineral density data on bisphosphonates in postmenopausal osteoporosis.
McClung MR
Bone; 1996 Nov; 19(5 Suppl):195S-198S. PubMed ID: 8922662
[TBL] [Abstract][Full Text] [Related]
3. The use of bisphosphonates in the treatment of osteoporosis.
Papapoulos SE; Landman JO; Bijvoet OL; Löwik CW; Valkema R; Pauwels EK; Vermeij P
Bone; 1992; 13 Suppl 1():S41-9. PubMed ID: 1581119
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of bisphosphonates against osteoporosis in adult men: a meta-analysis of randomized controlled trials.
Chen L; Wang G; Zheng F; Zhao H; Li H
Osteoporos Int; 2015 Sep; 26(9):2355-63. PubMed ID: 25944731
[TBL] [Abstract][Full Text] [Related]
5. [Measurement of bone mineral density is necessary for monitoring of bisphosphonate treatment].
Soen S
Clin Calcium; 2011 Jan; 21(1):116-9. PubMed ID: 21187604
[TBL] [Abstract][Full Text] [Related]
6. [Long-term bisphosphonate administration and its effect on bone metabolism].
Hagino H
Clin Calcium; 2005 Apr; 15(4):643-7. PubMed ID: 15802778
[TBL] [Abstract][Full Text] [Related]
7. Bisphosphonates: preclinical aspects and use in osteoporosis.
Fleisch HA
Ann Med; 1997 Feb; 29(1):55-62. PubMed ID: 9073324
[TBL] [Abstract][Full Text] [Related]
8. [Bisphosphonates in osteoporosis therapy. Standards and perspectives].
Reinsdorf S; Habermann B; Hochmuth K; Kurth AA
Orthopade; 2007 Feb; 36(2):110-7. PubMed ID: 17252258
[TBL] [Abstract][Full Text] [Related]
9. Prevention of bone loss and vertebral fractures in patients with chronic epilepsy--antiepileptic drug and osteoporosis prevention trial.
Lazzari AA; Dussault PM; Thakore-James M; Gagnon D; Baker E; Davis SA; Houranieh AM
Epilepsia; 2013 Nov; 54(11):1997-2004. PubMed ID: 24010637
[TBL] [Abstract][Full Text] [Related]
10. Bisphosphonates for osteoporosis in people with cystic fibrosis.
Brenckmann C; Papaioannou A
Cochrane Database Syst Rev; 2001; (4):CD002010. PubMed ID: 11687132
[TBL] [Abstract][Full Text] [Related]
11. Present and future of osteoporosis therapy.
Seeman E; Tsalamandris C; Bass S; Pearce G
Bone; 1995 Aug; 17(2 Suppl):23S-29S. PubMed ID: 8579894
[TBL] [Abstract][Full Text] [Related]
12. Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis.
Chesnut CH; Skag A; Christiansen C; Recker R; Stakkestad JA; Hoiseth A; Felsenberg D; Huss H; Gilbride J; Schimmer RC; Delmas PD;
J Bone Miner Res; 2004 Aug; 19(8):1241-9. PubMed ID: 15231010
[TBL] [Abstract][Full Text] [Related]
13. Aging bone and osteoporosis: strategies for preventing fractures in the elderly.
Ettinger MP
Arch Intern Med; 2003 Oct; 163(18):2237-46. PubMed ID: 14557222
[TBL] [Abstract][Full Text] [Related]
14. [Bisphosphonates and combined treatments osteoporosis].
Rizzoli R; Ferrari S
Rev Med Suisse; 2005 Oct; 1(35):2266, 2269-71. PubMed ID: 16268449
[TBL] [Abstract][Full Text] [Related]
15. Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate.
Seibel MJ; Naganathan V; Barton I; Grauer A
J Bone Miner Res; 2004 Feb; 19(2):323-9. PubMed ID: 14969403
[TBL] [Abstract][Full Text] [Related]
16. Bisphosphonates.
McClung M
Arq Bras Endocrinol Metabol; 2006 Aug; 50(4):735-44. PubMed ID: 17117298
[TBL] [Abstract][Full Text] [Related]
17. Clinical effects of bisphosphonates in involutional osteoporosis.
Ott SM
J Bone Miner Res; 1993 Dec; 8 Suppl 2():S597-606. PubMed ID: 8122531
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics/pharmacodynamics of bisphosphonates: use for optimisation of intermittent therapy for osteoporosis.
Cremers SC; Pillai G; Papapoulos SE
Clin Pharmacokinet; 2005; 44(6):551-70. PubMed ID: 15932344
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of Zoledronic Acid for Treatment of Postmenopausal Osteoporosis: A Meta-Analysis of Randomized Controlled Trials.
Wang C
Am J Ther; 2017; 24(5):e544-e552. PubMed ID: 26938765
[TBL] [Abstract][Full Text] [Related]
20. Effects of the bisphosphonate tiludronate on bone resorption, calcium balance, and bone mineral density.
Ammann P; Rizzoli R; Caverzasio J; Shigematsu T; Slosman D; Bonjour JP
J Bone Miner Res; 1993 Dec; 8(12):1491-8. PubMed ID: 8304051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]